Ad
related to: gsk
Search results
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
InvestorPlace· 7 hours agoMany investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 12 hours ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
GSK Stock Slumps on Zantac Setback
The Wall Street Journal· 9 hours agoGSK shares (UK:GSK, GSK) dropped after a state court in Delaware said it would allow more than 70,000 cases that allege its Zantac heartburn ...
GSK Stock Dips on Delaware Court Ruling for Zantac Litigation
Zacks via Yahoo Finance· 11 hours agoGSK shares decline more than 7% in pre-market trading on Monday in response to an unfavorable ruling...
Zantac Heart Burn Continues For GSK As US Court Ruling Allows Thousands Of Zantac Lawsuits To Move...
Benzinga via Yahoo Finance· 11 hours agoOn Monday, GSK Plc (NYSE:GSK) shares were down after the Delaware State Court ruled that more than...
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated...
Benzinga via Yahoo Finance· 6 hours agoOn Sunday, GSK plc (NYSE:GSK) released results from an interim analysis of the DREAMM-8 phase 3...
GSK Plc ADR (NYSE: GSK): Performance Review And Forecast – Marketing Sentinel
Marketing Sentinel· 10 hours agoIn today’s recent session, 6.61 million shares of the GSK Plc ADR (NYSE:GSK) have been traded, and its beta is 0.67. Most recently the company’s share price ...
Is GSK stock a sell with 75,000 Zantac cases moving forward? | Invezz
Invezz· 11 hours agoGSK plc (NYSE:GSK) faced a significant setback on June 3rd when its stock plunged by 8% following a...
GSK reports 100% response in rectal cancer study with Jemperli By Investing.com
Investing.com· 9 hours agoGSK plc (LSE/NYSE: LON:GSK) has shared updated results from a phase II study conducted in...
FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble
Evening Standard via Yahoo Finance· 11 hours agoGSK shares are today’s major focus after the drugs giant’s defence against Zantac claims suffered a...
